FIRST AMENDMENT TO CONTINGENT VALUE RIGHTS AGREEMENT March 23, 2021Contingent Value Rights Agreement • March 24th, 2021 • NeuroBo Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 24th, 2021 Company Industry JurisdictionThis Amendment (this “Amendment”) is made and entered into as of the date first written above, and amends that certain Contingent Value Rights Agreement (the “Agreement”), dated as of December 30, 2019, by and among Gemphire Therapeutics Inc. a Delaware corporation (“Gemphire”), Grand Rapids Holders’ Representative, LLC, as representative of Holders (“Holders’ Representative”), and Computershare Inc. and Computershare Trust Company, N.A., jointly, as rights agent (“Rights Agent”). Capitalized terms used herein without definition shall have the meanings ascribed to such terms in the Agreement.